SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GUFIC BIOSCIENCES

BSE: 509079 30 Sep 2025
Healthcare
₹ 368.85
Gufic BioSciences Ltd. specializes in Pharmaceuticals within the Healthcare sector.

GUFIC BIOSCIENCES - Share Price & Details

Market Cap
₹3,590
High /Low
504.0 / 285.0
Stock P/E
58.0
Book Value
₹59.9
Dividend Yield
0.03
ROCE
13.0
ROE
₹12.3
Face Value
1.0
PEG Ratio
NA
EVEBITDA
₹28.8
Debt
336
CMP / FCF
NA
Debt to equity
₹0.56
NP Ann
69.6
High price all time
504.0
Piotroski score
₹5.0
Graham Number
91.2
No. Eq. Shares
10.0
Net CF
₹14.6
Net profit
61.9
Price to book value
5.97
Interest Coverage
₹4.01
Low price all time
2.46
Industry PE
33.0
Reserves
₹591
Free Cash Flow
₹51.8

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
GUFIC BIOSCIENCES LTD.2278.06120.732269.111.23,59058.0
Advanced Enzyme Technologies L1788.76739.811250.246.61358026.2
UNICHEM LABORATORIES LTD.3885.0-18.53842.5-0.26337227.0

Peer Comparison Chart


About GUFIC BIOSCIENCES

Gufic BioSciences Ltd., with Security Code 509079, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

How Gufic Biosciences Limited Performs During Inflation Historical Overview - Price Support Zones & High Profit Trading Signals

(28 Sep 2025)
【Stock Watchlist】✌️ Expert-curated stock picks with global market trend analysis at your fingertips.
Read more →

Gufic BioSciences Faces Mixed Technical Signals Amid Market Fluctuations

(26 Sep 2025)
Gufic BioSciences, a small-cap pharmaceutical company, has seen its stock price decline recently, with a year-to-date return of -6.09%.
Read more →

Gufic BioSciences Shows Mixed Technical Trends Amid Long-Term Growth Resilience

(24 Sep 2025)
Gufic BioSciences, a small-cap pharmaceutical company, has seen a recent stock price increase, despite a year-to-date decline. Technical indicators present...
Read more →

Gufic BioSciences Shows Mixed Technical Trends Amidst Long-Term Growth Resilience

(22 Sep 2025)
Gufic BioSciences, a small-cap pharmaceutical company, has seen its stock price rise recently, despite a year-over-year decline.
Read more →

Gufic BioSciences Faces Bearish Technical Trends Amid Market Challenges

(19 Sep 2025)
Gufic BioSciences, a small-cap pharmaceutical company, has experienced a recent stock price decline amid bearish market indicators.
Read more →

Gufic BioSciences Faces Mixed Technical Trends Amid Market Evaluation Revision

(19 Sep 2025)
Gufic BioSciences, a small-cap pharmaceutical company, has seen its stock price rise recently, despite a year-over-year decline.
Read more →